Diffuse Large B-cell lymphoma |
OCI-Ly1, OCI-Ly18, SU-DHL-7 |
Up |
FOXO1 |
FoxO signaling pathway |
miR-21 plays an important oncogenic role by down regulating the expression of FOXO1 and modulating the FOXO1 pathway in Diffuse Large B-cell lymphoma. |
Go et al., 2015 |
Diffuse Large B-cell lymphoma |
OCI-Ly1, OCI-Ly18, SU-DHL-7 |
Up |
PTEN |
PI3K-Akt signaling pathway |
miR-21 plays an important oncogenic role by down regulating the expression of PTEN and modulating the PI3K-Akt signaling pathway in Diffuse Large B-cell lymphoma. |
Go et al., 2015 |
Diffuse Large B-cell lymphoma |
OCI-Ly1, OCI-Ly18, SU-DHL-7 |
Up |
PTEN |
mTOR pathway |
miR-21 plays an important oncogenic role by down regulating the expression of PTEN and modulating the mTOR pathway in Diffuse Large B-cell lymphoma. |
Go et al., 2015 |
Sezary syndrome |
HuT 78, H9, HH |
Up |
PTEN |
PI3K-Akt signaling pathway |
Overexpression of hsa-miR-21 downregulates the expression of PTEN. Reduced PTEN activates the PI3/AKT-mediated pathway of cell growth and survival. |
Cristofoletti et al., 2013 |
Diffuse Large B-cell lymphoma |
CRL2631 |
Up |
PTEN |
PI3K-Akt signaling pathway |
hsa-miR-21 regulates the PI3K-Akt signaling pathway through the regulation of PTEN, thereby affecting cellular sensitivity to the CHOP chemotherapeutic regimen. |
Bai et al., 2013 |
Alzheimer's disease |
Cerebral cortex |
Down |
PTEN |
PI3K-Akt signaling pathway |
MicroRNA-212 regulates cell survival by direct suppression of PTEN, which is the key elements of AKT signaling pathway. |
Wong et al., 2013 |
Alzheimer's disease |
Cerebral cortex |
Down |
FOXO3A |
FoxO signaling pathway |
MicroRNA-212 regulates cell survival by direct suppression of FOXO3a, which is the key elements of AKT signaling pathway. |
Wong et al., 2013 |
Multiple sclerosis |
COS-7 |
Up |
SMAD4 |
TGF-beta signaling pathway |
Over-expression of miR-212 suppresses the expression of SMAD4. MicroRNA-212 targets TGF-beta signaling, and dampens the development of regulatory T cell, thereby increasing susceptibility to developing multiple sclerosis. |
Severin et al., 2016 |
Hepatitis C virus infection |
HEK293 |
Up |
MYD88 |
IFN signaling pathway |
MicroRNA-21 is over-expressed during HCV infection and down-regulates IFN signaling pathway via targeting MyD88. |
Chen et al., 2014 |
Hepatitis C virus infection |
HEK293 |
Up |
IRAK1 |
IFN signaling pathway |
MicroRNA-21 is over-expressed during HCV infection and down-regulates IFN signaling pathway via targeting IRAK1. |
Chen et al., 2014 |
Chronic hepatitis C virus infection |
Huh-7.5 |
Up |
SMAD7 |
TGF-beta signaling pathway |
MicroRNA-21 down-regulates the expression of SMAD7 and enhances TGF-beta signaling, leads to increase fibrogenesis. |
Marquez et al., 2010 |
Gastric cancer |
Gastric cancer tissue |
Up |
PTEN |
PI3K-Akt signaling pathway |
MicroRNA-21 enhances the phosphorylation of Akt through dropping PTEN which promotes the epithelial-mesenchymal transition in gastric cancer induced by TGF-beta 1. |
Liet al., 2016 |
Hepatocellular carcinoma |
Stomach |
Down |
RBP2 |
CDK pathway |
Upregulation of hsa-miR-212 down-regulates the expression of RBP2 and suppresses cell proliferation in hepatocellular carcinoma. |
Liang et al., 2013 |
Gastric cancer |
SGC-7901 |
Up |
PTEN |
PI3K-Akt signaling pathway |
hsa-miR-21 promotes cell survival and cisplatin resistance in gastric cancer through inhibiting phosphatase and tension homolog deleted on chromosome 10 (PTEN) expression level and activation of PI3K-Akt signaling pathway. |
Yang et al., 2013 |
Gastric cancer |
MKN-45, SGC-7901 |
Down |
ROBO1 |
Slit/Robo pathway |
Overexpression of miR-218 inhibits Robo1 expression and isuppresses tumor cell invasion and metastasis in gastric cancer. |
Tie et al., 2010 |
Hepatocellular carcinoma |
Hep-G2 |
Up |
HBP1 |
p53 signaling pathway |
MicroRNA-21 induces hepatocellular carcinoma progression through targeting Hbp1-p53-Srebp1c pathway. |
Wu et al., 2015 |
Non-alcoholic fatty liver disease |
Hep-G2 |
Up |
HBP1 |
p53 signaling pathway |
MicroRNA-21 induces hepatic lipid accumulation through targeting Hbp1-p53-Srebp1c pathway. |
Wu et al., 2015 |
Lung cancer |
A-549,NCI-H1650 |
Up |
CTNNBIP1 |
Wnt signaling pathway |
MicroRNA-214 plays an important role in cancer stem-like cells self-renewal and stemness by down-regulating the expression of CTNNBIP1 in lung adenocarcinoma. |
Qi et al., 2015 |
Non-small cell lung cancer |
Lung |
Up |
PTEN |
NF-Kappa B signaling pathway |
Suppression of NF-Kappa B signaling pathway enhances cisplatin sensitivity in non-small cell lung cancer. |
Yang et al., 2015 |
Lung cancer |
A-549 |
Up |
|
PI3K-Akt signaling pathway |
Inhibition of miR-21 reverses lung cancer cell multi drug resistance through inhibition of the Akt signaling pathway. |
Dong et al., 2015 |
Breast cancer |
Breast |
Up |
PTEN |
PI3K-Akt signaling pathway |
MicroRNA-214 functions as oncogene in breast cancer by inhibiting the PI3K-Akt signaling pathway. |
Wang et al., 2016 |
Breast cancer |
MCF-7 |
|
PTEN |
PI3K-Akt signaling pathway |
MiR-21 regulates autophagy and apoptosis by suppression phosphatase and tensin homolog (PTEN) through targeting PI3K-Akt signaling pathway. |
Yu et al., 2016 |
Breast cancer |
4T1 |
Up |
PTEN |
PI3K-Akt signaling pathway |
MicroRNA-21 functions as a fine tuner in the regulation of PI3K-Akt signaling pathway in the expansion of CCR6(+) Tregs in tumor sites. |
Hu et al., 2015 |
Hepatocellular carcinoma |
Hepatocyte |
Up |
PTEN |
PI3K-Akt signaling pathway |
Overexpression of hsa-miR-21 reduces PTEN expression and sequential Akt activation. It suppresses autophagy through PI3K-Akt signaling pathway. |
He et al., 2015 |
Non-alcoholic fatty liver disease |
Hep-G2 |
Up |
HBP1 |
p53 signaling pathway |
Downregulation of hsa-miR-21 increases expression of HBP1 and p53 and decreased lipogenesis. miR-21 stimulates hepatic lipid accumulation and cancer development through modulation of Hbp1-p53-Srebp1c pathway. |
Wu et al., 2015 |
Hepatocellular carcinoma |
Hepatocyte |
Down |
IGF2BP2 |
IGF signaling pathway |
Overexpression of hsa-miR-216b suppresses HCC cell proliferation and invasion by targeting IGF2BP2 through HBx-miR-216b-IGF2BP2 signaling pathway. |
Liu et al., 2015 |
Hepatocellular carcinoma |
Hepatocyte |
Down |
HOXA10 |
PI3K-Akt signaling pathway |
Overexpression of miR-218 reduces cancer cell proliferation in hepatocellular carcinoma through PI3K-Akt signaling pathway with possible association of HoxA10. |
Xiao et al., 2014 |
Hepatocellular carcinoma |
Hepatocyte |
Up |
MAP2K3 |
MAPK signaling pathway |
Overexpression of miR-21 post-transcriptionally inhibits MAP2K3 signaling in hepatocellular carcinoma cell development. |
Xu et al., 2013 |
Cervical cancer |
HeLa, SiHa |
Up |
|
PI3K-Akt signaling pathway |
MicroRNA-21 confers reduced autophagy in cervical cancer cells through the PI3K-Akt signaling pathway. |
Song et al., 2016 |
Cervical cancer |
HeLa, Ca Ski |
Up |
PTEN |
PTEN pathway |
MicroRNA-21 induces proliferation, migration and invasion in cervical cancer cells through targeting the PTEN expression. |
Xu et al., 2015 |
Renal cell carcinoma |
A-498, 786-O |
|
CAV2 |
Focal adhesion pathway |
MicroRNA-218 suppresses cell migration and invasion in renal cell carcinoma by inhibiting caveolin-2 expression. |
Yamasaki et al., 2013 |
Medullary thyroid carcinoma |
Thyroid gland |
Up |
PDCD4 |
PDCD4 pathway |
MicroRNA-21 regulates the expression of PDCD4 in medullary thyroid carcinoma. |
Pennelli et al., 2015 |
Osteosarcoma |
MG-63 |
Up |
PTEN |
PI3K-Akt signaling pathway |
MicroRNA-21 plays an active role in osteosarcoma through PI3K-Akt signaling pathway by inhibiting PTEN expression. |
Lv et al., 2016 |
Pancreatic carcinoma |
PANC-1 |
Down |
JAK2 |
Jak-STAT signaling pathway |
MicroRNA-216a acts as a tumor suppressor in pancreatic cancer cells by inhibiting the Jak-STAT signaling pathway. |
Hou et al., 2015 |
Asthma |
Airway smooth muscle |
Up |
PTEN |
PI3K-Akt signaling pathway |
MicroRNA-21 enhanced proliferation and migration of human airway smooth muscle (HASM) cell in asthma through activation of phosphoinositide 3 kinase pathway. |
Liu et al., 2015 |
Atherosclerosis |
Peripheral blood mononuclear cells |
Up |
TGFBR |
TGF-beta signaling pathway |
Overexpression of miR-21 downregulates the frequency of circulating Treg cells through TGF-beta signaling pathway in atherosclerosis. |
Li et al., 2015 |
Atherosclerosis |
Peripheral blood mononuclear cells |
Up |
SMAD7 |
TGF-beta signaling pathway |
Overexpression of miR-21 downregulates the frequency of circulating Treg cells through TGF-beta signaling pathway in atherosclerosis. |
Li et al., 2015 |
Chronic pancreatitis |
PANC-1, BxPC-3 |
Down |
SIRT1 |
SIRT1 pathway |
Expression of miR-217 is significantly decreased in chronic pancreatitis cell and its expression is negatively correlated with SIRT1 expression. |
Deng et al., 2014 |
Alcoholic liver disease |
Hepatic stellate cells |
Up |
FAS |
Apoptosis pathway |
Downregulation of miR-21 increased the expression of FASL in alcoholic liver injury. |
Francis et al., 2014 |